Scientists develop Novel Stem Cell Therapy for Cardiac Regeneration in MI

A team of scientists from the City University of Hong Kong (CityU) has developed a novel stem cell-based treatment for Cardiac Regeneration in Myocardial Infarction (MI) patients. The efficacy of the therapy was reported in Nature Communications.

It is the first study to look at the effect of both Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMS) and Human Marrow Stromal Cells (hMSCs) on MI simultaneously.

MI is a fatal disorder caused by a shortage of coronary blood supply to the myocardium. It leads to permanent loss of heart muscle cells, called cardiomyocytes (CMs), and scar tissue formation, resulting in irreversible damage to cardiac function or even heart failure. With limited therapeutic options for severe MI and advanced heart failure, a heart transplant is the last resort. But it is very risky, costly and subject to limited suitable donors. Therefore, stem cell-based therapy has emerged as a promising therapeutic option.

The novel cell-based therapy is a multipronged approach for concurrently rejuvenating both the muscle cells and vascular systems of the heart by utilizing two types of stem cells. The findings give hope to develop a new treatment for repairing MI heart, as an alternative to the existing complex and risky heart transplant for seriously-ill patients.

Dr Ban Kiwon, a stem cell biologist from the Department of Biomedical Sciences at CityU, has been focusing on developing novel stem cell-based treatments for cardiac regeneration. “Heart is an organ composed of cardiac muscles and blood vessels, where vessels are essential to supply oxygen and energy to the muscles. Since both cardiac muscles and vasculatures would be severely damaged following MI, the therapeutic strategies should focus on comprehensive repair of both at the same time. But so far the strategies only focus on either one,” he explains.

In this regard, Dr Ban and his collaborators, including researchers from Konkuk University, The Catholic University of Korea, Pohang University of Science and Technology, and T&R Biofabin South Korea, have recently developed a multipronged approach. It aimed to concurrently rejuvenate both the heart muscles and the vasculatures by utilizing two major types of stem cells, namely human bone marrow-derived mesenchymal stem cells (hMSCs) and cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs).

The hMSCs was employed in the study due to their prominent paracrine activity of secreting good proteins to promote the regeneration of blood vessels and the endothelial cell survival. And the hiPSC-CMs was utilized for their similarities with human primary CMs in terms of the expressions of cardiac-specific genes, structural proteins, ion channels, and more importantly, the spontaneous contraction.

The first study of two distinct stem cell effects for cardiac repair

While several previous studies described the beneficial effects of either hiPSC-CMS or hMSCs on MI separately, this is the study to simultaneously examine the effects of these two distinct stem cells in cardiac repair. The researchers have adopted a dual approach, in which the hMSCs and the hiPSC-CMs were delivered via two distinct routes. The hiPSC-CMs were intramyocardially injected directly into border zone of the rat’s heart, while the hMSCs-loaded patch was implanted on top of the infarct area, like a bandage.

Schematic diagram of the underlying mechanism of dual treatment approach of hiPSC-CMs and hMSC- patch.

The results showed that this dual approach led to a significant improvement of cardiac function and enhancement of vessel formation on an MI heart. The implanted hMSC-loaded patch not only provided a micro-environment which enhanced vascular regeneration as expected but also improved the retention of hiPSC-CMs, ultimately augmenting heart function and restoring the injured myocardium.

Moreover, histological analyses results demonstrated that the implantation of the hMSC-loaded patch has promoted the functional maturation of injected hiPSC-CMs.They became more elongated and rectangular in cell shape, appeared to be more organized in order, which was typical morphological characteristics of matured adult CMs. Functional maturation of intramyocardially injected hiPSC-CMs is particularly important. It is because it can reduce the potential risk of arrhythmias, meaning irregular heart contraction, which is a major cause of sudden cardiac death.

Application potential in cardiac regeneration and beyond

“We believe this novel dual approach can potentially provide translational and clinical benefit to the field of cardiac regeneration,” said Dr Ban. “Based on the same principle, the protocol may also be utilized for repairing other organs including brain, liver, and pancreas in which multiple types of stem cells are co-existing.”The team is working on follow-up studies in a larger animal model such as pigs. The patent application has been submitted.